Similarly, the ALK ligand pleiotrophin (PTN) is elevated in serum and tissues from pancreatic cancer patients [17], and it has been shown that PTN levels are associated with the malignant progression of human pancreatic cancer, demonstrating the clinical significance of this signaling pathway [14]. This evidence concerns the gene PTN and familial pancreatic carcinoma.